← Leaderboards
Mark T Heise
University Of North Carolina Chapel Hill
$26,876,746
Attributed
$30,056,732
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,665,150 · 17
By mechanism
U19$50,969,998 · 5
R01$9,265,722 · 4
R21$2,062,871 · 5
T32$1,887,844 · 1
P01$1,516,763 · 1
U54$961,952 · 1
Top collaborators
- Ralph S Baric23 shared
- Jennifer Y Webster-Cyriaque6 shared
- Nathaniel J Moorman4 shared
- Cary A Moody3 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Robert E. Johnston$11,943,669
- Aravinda M De Silva$31,411,437
- William B Klimstra$13,808,129
- David G. Kaufman$11,124,850
- Ralph S Baric$89,182,261
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusVirus DiseasesAffectPathway InteractionsImmune ResponseInfectionPathogenesisImmuneGenesPathogenResponsePhenotypeMediatingProgramsAlphavirusImmunityShapesVariantIn VivoViralInsightSars CoronavirusQuantitative Trait LociGenetic
Grant awards (89)
Molecular Biology of Viral Diseases Predoctoral Training Grant$249,505
T32 · FY2025 · AI · contact PI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross$766,144
R01 · FY2024 · AI · contact PI
Molecular Biology of Viral Diseases Predoctoral Training Grant$198,475
T32 · FY2024 · AI · contact PI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross$766,144
R01 · FY2023 · AI · contact PI
Molecular Biology of Viral Diseases Predoctoral Training Grant$190,674
T32 · FY2023 · AI · contact PI
Development of Broad Spectrum Direct Acting Antivirals Against Emerging Alphaviruses$7,100,428
U19 · FY2022 · AI · contact PI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross$766,144
R01 · FY2022 · AI · contact PI
Molecular Biology of Viral Diseases Predoctoral Training Grant$189,753
T32 · FY2022 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$2,298,830
U19 · FY2021 · AI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross$766,144
R01 · FY2021 · AI · contact PI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$420,945
U19 · FY2021 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$309,479
U19 · FY2021 · AI
Molecular Biology of Viral Diseases Predoctoral Training Grant$172,154
T32 · FY2021 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$91,160
U19 · FY2021 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$2,332,322
U19 · FY2020 · AI
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross$748,384
R01 · FY2020 · AI · contact PI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$564,671
U19 · FY2020 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$564,671
U19 · FY2020 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$563,507
U19 · FY2020 · AI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$563,507
U19 · FY2020 · AI · contact PI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$492,473
U19 · FY2020 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$412,634
U19 · FY2020 · AI
Molecular Biology of Viral Diseases Predoctoral Training Grant$203,363
T32 · FY2020 · AI · contact PI
Testing the role of NLRP3 and other NLR Family Members in COVID19 pathogenesis$103,161
U19 · FY2020 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$91,160
U19 · FY2020 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$2,769,729
U19 · FY2019 · AI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$499,496
U19 · FY2019 · AI · contact PI
Molecular Biology of Viral Diseases Predoctoral Training Grant$242,086
T32 · FY2019 · AI · contact PI
Defining Functional RNA Structures in an Arthritic Alphavirus Genome$192,793
R21 · FY2019 · AI · contact PI
Molecular Characterization of Functional RNA Structures in the ZIKV genome$192,793
R21 · FY2019 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$2,727,484
U19 · FY2018 · AI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$489,101
U19 · FY2018 · AI · contact PI
Defining Functional RNA Structures in an Arthritic Alphavirus Genome$231,668
R21 · FY2018 · AI · contact PI
Molecular Characterization of Functional RNA Structures in the ZIKV genome$231,668
R21 · FY2018 · AI · contact PI
Molecular Biology of Viral Diseases Predoctoral Training Grant$207,970
T32 · FY2018 · AI · contact PI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross$2,437,629
U19 · FY2017 · AI
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross$591,594
U19 · FY2017 · AI · contact PI
Host Genetic Control of Chikungunya Virus-induced Arthritis$190,000
R21 · FY2017 · AI · contact PI
Expression, Biochemistry and Immune Reagent Core$173,858
U19 · FY2017 · AI · contact PI
Molecular Biology of Viral Diseases Predoctoral Training Grant$149,973
T32 · FY2017 · AI · contact PI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross$4,853,040
U19 · FY2016 · AI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L$503,745
U19 · FY2016 · AI · contact PI
Expression, Biochemistry and Immune Reagent Core$376,847
U19 · FY2016 · AI · contact PI
Host Genetic Control of Chikungunya Virus-induced Arthritis$228,000
R21 · FY2016 · AI · contact PI
Unlocking Zika Virus Immune Control and Pathogenesis with the Collaborative Cross$135,110
U19 · FY2016 · AI
Molecular Biology of Viral Diseases Predoctoral Training Grant$83,891
T32 · FY2016 · AI · contact PI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross$4,144,540
U19 · FY2015 · AI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L$412,964
U19 · FY2015 · AI · contact PI
Expression, Biochemistry and Immune Reagent Core$345,363
U19 · FY2015 · AI · contact PI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross$4,148,261
U19 · FY2014 · AI
Expression, Biochemistry and Immune Reagent Core$393,023
U19 · FY2014 · AI · contact PI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L$334,030
U19 · FY2014 · AI · contact PI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross$4,030,980
U19 · FY2013 · AI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L$367,974
U19 · FY2013 · AI · contact PI
Expression, Biochemistry and Immune Reagent Core$348,018
U19 · FY2013 · AI · contact PI
Pathogenesis of Chikungunya virus$196,637
U54 · FY2013 · AI · contact PI
TRIM Interactions with Arthritic Alphaviruses$181,885
R21 · FY2013 · AI · contact PI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross$4,594,721
U19 · FY2012 · AI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L$383,543
U19 · FY2012 · AI · contact PI
Immune Evasion Mechanisms of Neurovirulent Alphaviruses$286,000
R01 · FY2012 · AI · contact PI
TRIM Interactions with Arthritic Alphaviruses$218,946
R21 · FY2012 · AI · contact PI
Pathogenesis of Chikungunya virus$213,207
U54 · FY2012 · AI · contact PI
Immune Evasion Mechanisms of Neurovirulent Alphaviruses$286,000
R01 · FY2011 · AI · contact PI
Pathogenesis of Chikungunya virus$201,452
U54 · FY2011 · AI · contact PI
Improved Vaccines for Rift Valley Fever Virus$456,399
R01 · FY2010 · AI · contact PI
Togavirus Tropism for Bones, Joints, and CNS$291,336
R01 · FY2010 · AR · contact PI
Immune Evasion Mechanisms of Neurovirulent Alphaviruses$288,889
R01 · FY2010 · AI · contact PI
Pathogenesis of Chikungunya virus$237,541
U54 · FY2010 · AI · contact PI
Improved Vaccines for Rift Valley Fever Virus$473,894
R01 · FY2009 · AI · contact PI
Core-- Animal Models$316,112
P01 · FY2009 · AI · contact PI
Togavirus Tropism for Bones, Joints, and CNS$299,330
R01 · FY2009 · AR · contact PI
Immune Evasion Mechanisms of Neurovirulent Alphaviruses$291,249
R01 · FY2009 · AI · contact PI
Togavirus Tropism for Bones, Joints, and CNS$215,469
R01 · FY2009 · AR · contact PI
Pathogenesis of Chikungunya virus$113,115
U54 · FY2009 · AI · contact PI
Improved Vaccines for Rift Valley Fever Virus$473,040
R01 · FY2008 · AI · contact PI
Core-- Animal Models$306,973
P01 · FY2008 · AI · contact PI
Togavirus Tropism for Bones, Joints, and CNS$299,330
R01 · FY2008 · AR · contact PI
Immune Evasion Mechanisms of Neurovirulent Alphaviruses$287,982
R01 · FY2008 · AI · contact PI
Arbovirus Evasion of Type I Interferon Induction$177,589
R21 · FY2008 · AI · contact PI
Togavirus Tropism for Bones, Joints, and CNS$315,329
R01 · FY2007 · AR · contact PI
Core-- Animal Models$310,041
P01 · FY2007 · AI · contact PI
Arbovirus Evasion of Type I Interferon Induction$217,529
R21 · FY2007 · AI · contact PI
Core-- Animal Models$286,575
P01 · FY2006 · AI · contact PI
Core-- Animal Models$297,062
P01 · FY2005 · AI
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS$237,703
R01 · FY2004 · AR
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS$237,703
R01 · FY2003 · AR
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS$237,703
R01 · FY2002 · AR
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS$237,703
R01 · FY2001 · AR
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS$237,703
R01 · FY2000 · AR